Table 1 Baseline characteristics of study participants in the therapeutic efficacy study of artemether-lumefantrine for the treatment of uncomplicated P. falciparum malaria, Shecha health centre, Arba Minch, Ethiopia, 2021
Patient characteristics | Age group | ||||
|---|---|---|---|---|---|
(0–5) | [5–15) | ≥ 15 | Total | ||
Mean age (range) | 3.3 (2–4.9) | 10.2 (5–14) | 27.8 (15–73) | 18.6 (2–73) | |
Gender | |||||
 Male n (%) | 3 (37.5) | 24 (68.6) | 29 (64.4) | 56 (63.6) | |
 Female n (%) | 5 (62.5) | 11 (31.4) | 16 (35.6) | 32 (36.4) | |
Weight (kg), mean (SD) | 14.1 (2.9) | 29.4 (10.3) | 56.1 (9.1) | 41.6 (18.0) | |
Temperature (°C), mean (SD) | 38.1 (1.3) | 38.0 (1.2) | 38.2 (1.3) | 38.1 (1.2) | |
Parasitaemia (per µl), geometric mean (range) | 17978.4 (3120–134125) | 14809.5 (200–79160) | 9359.7 (1000–76,440) | 11920.5 (200–134125) | |
Gametocyte carriage n (%) | 0 (0.0) | 1 (2.9) | 2 (4.4) | 3 (3.4) | |
Haemoglobin (g/dl), mean (SD) | 10.9 (1.6) | 11.8 (1.8) | 12.7 (1.9) | 12.2 (1.9) | |